kit for the preparation of technetium tc 99m albumin aggregated
TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT (kit for the preparation of technetium tc 99m albumin aggregated) by Jubilant Therapeutics is injection, more than 80% of the technetium tc 99m albumin aggregated particles is trapped in the pulmonary alveolar capillary bed within 5 minutes. First approved in 1987.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
Technetium Tc 99m Albumin Aggregated is a radioactive diagnostic imaging agent used for pulmonary perfusion scintigraphy and peritoneal shunt patency studies. The kit enables preparation of a radiopharmaceutical where aggregated albumin particles lodge in pulmonary capillaries or distribute in peritoneal fluid to assess circulation and shunt function. This injectable diagnostic agent helps clinicians visualize pulmonary blood flow and detect portosystemic shunt complications.
This legacy diagnostic product faces approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team consolidation or transition planning.
injection, more than 80% of the technetium Tc 99m albumin aggregated particles is trapped in the pulmonary alveolar capillary bed within 5 minutes. Following intraperitoneal injection, technetium Tc 99m albumin aggregated mixes with the peritoneal fluid. Clearance from the peritoneal cavity varies…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career opportunities on this product are limited given the LOE-approaching lifecycle stage and zero linked job postings. Roles available are primarily in medical affairs support, regulatory compliance, and legacy product management rather than growth-focused positions.
Worked on TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.